Company intelligence / Profile preview

e-Zyvec

Strasbourg, France

Ownership: Private
Development stage: Other

Overview

e-Zyvec provides DNA design and production services for tailor-made plasmid DNA vectors used as tools in gene therapy, biomanufacturing and research; it does not develop its own therapeutic pipeline but supports others’ R&D and manufacturing workflows.

Modalities: DNA vectorPlasmid DNAGene therapyCell therapy
Industry: Drug Discovery Services

Partnerships

Polyplus (integration as an acquired business unit for cell and gene therapy upstream solutions)

Beyond the preview

Go deeper on e-Zyvec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on e-Zyvec.

Explore the full profile